follow
respiratori
tract
sampl
analyz
merscov
load
determin
threshold
cycl
ct
valu
proport
merscov
genom
obtain
sputum
sampl
nasopharyng
swab
sampl
tracheal
aspir
bronchoalveolar
lavag
specimen
sputum
specimen
collect
directli
steril
leakproof
screw
cap
contain
nasopharyng
swab
specimen
collect
use
steril
synthet
dacron
flock
swab
swab
insert
nostril
parallel
palat
nasopharynx
left
place
second
absorb
secret
swab
place
immedi
steril
tube
contain
ml
viral
transport
medium
lower
respiratori
tract
sampl
ml
tracheal
aspir
bronchoalveolar
lavag
fluid
obtain
place
dri
steril
leakproof
screw
cap
contain
transport
specimen
perform
previous
describ
brief
short
period
hour
transport
specimen
kept
transport
durat
hour
specimen
ship
frozen
dri
ice
soon
possibl
collect
specimen
contain
label
patient
identifi
specimen
type
sampl
collect
date
packag
perform
prevent
breakag
spillag
contain
seal
parafilm
place
ziplock
bag
suffici
absorb
materi
absorb
entir
content
spillag
occur
primari
contain
place
insid
secondari
contain
rna
extract
perform
describ
previous
use
roch
magna
pure
lc
rna
viral
isol
kit
sputum
sampl
pretreat
lysi
buffer
minut
shake
incub
swab
place
lysi
buffer
total
sampl
ad
magna
pure
lc
plate
contain
well
reaction
reagent
load
check
run
sampl
accord
manufactur
instruct
nucleic
acid
extract
specimen
prepar
area
clinic
sampl
screen
realtim
rtpcr
amplif
test
previous
describ
amplif
target
upstream
e
region
upe
confirm
result
consid
posit
assay
posit
first
second
assay
discord
realtim
rtpcr
result
ambigu
addit
clinic
sampl
request
analyz
merscov
deep
sequenc
conduct
previous
describ
merscov
genom
sequenc
analyz
publish
describ
previous
merscov
load
genom
fraction
record
set
sputum
specimen
nasopharyng
swab
specimen
tracheal
aspir
bronchoalveolar
lavag
sampl
standard
box
whisker
plot
median
valu
set
calcul
merscov
load
fraction
merscov
genom
obtain
fraction
merscov
genom
obtain
plot
sampl
viral
ct
valu
sampl
type
u
test
perform
comparison
p
valu
consid
statist
signific
comparison
merscov
realtim
rtpcr
ct
valu
function
sampl
type
perform
figur
upper
panel
tabl
show
p
valu
comparison
sampl
type
ct
valu
tracheal
aspir
yield
significantli
lower
merscov
ct
valu
ie
higher
viral
load
nasopharyng
swab
specimen
p
sputum
specimen
p
signific
differ
viral
load
ct
valu
tracheal
aspir
compar
bronchoalveolar
lavag
specimen
p
figur
lower
panel
show
merscov
genom
fraction
obtain
sampl
type
figur
show
correl
fraction
merscov
genom
obtain
sampl
ct
valu
rel
sampl
type
higher
merscov
genom
fraction
obtain
bronchoalveolar
lavag
sampl
tracheal
aspir
nasopharyng
swab
specimen
p
p
respect
sputum
sampl
p
p
respect
tabl
signific
differ
genom
yield
tracheal
aspir
bronchoalveolar
lavag
sampl
p
tabl
studi
present
largest
data
set
avail
date
molecular
analys
sever
type
respiratori
tract
sampl
describ
distribut
merscov
genom
load
fraction
viru
genom
sequenc
obtain
sampl
vari
amount
merscov
load
fraction
merscov
genom
obtain
clinic
sampl
type
receiv
saudi
arabian
patient
merscov
infect
stratifi
site
sampl
origin
sampl
deeper
respiratori
tract
ie
tracheal
aspir
bronchoalveolar
lavag
specimen
yield
significantli
higher
merscov
genom
load
genom
sequenc
fraction
sampl
respiratori
tract
ie
sputum
nasopharyng
swab
specimen
although
sampl
anatom
site
appear
suitabl
viral
load
determin
viru
genom
sequenc
studi
convent
test
detect
viral
infect
respiratori
tract
perform
sputum
nasopharyng
swab
specimen
patient
requir
admiss
intens
care
unit
tracheal
aspir
bronchoalveolar
lavag
sampl
patient
intens
care
unit
sampl
therefor
access
limit
studi
lack
multipl
sampl
multipl
compart
singl
patient
howev
given
limit
appear
viral
load
good
predictor
merscov
sequenc
success
viral
load
clinic
sampl
given
time
reflect
dynam
interact
merscov
replic
abil
host
immun
system
elimin
viru
thu
merscov
load
measur
clinic
use
monitor
diseas
activ
clinic
progress
respons
therapi
cure
also
use
marker
prognosi
ideal
approach
determin
appropri
clinic
sampl
make
diagnosi
ascertain
viral
load
obtain
optim
genom
fraction
requir
understand
natur
histori
viral
infect
data
sever
acut
respiratori
syndrom
sar
epidem
show
low
sarscov
load
upper
respiratori
tract
high
viral
load
lower
respiratori
tract
natur
histori
sarscov
infect
uniqu
test
result
nasopharyng
specimen
often
neg
first
week
infect
highest
posit
rate
occur
second
week
ill
peak
approxim
day
allow
definit
cours
infect
clinic
specimen
test
posit
low
viru
detect
rate
nasopharyng
specimen
earli
cours
sarscov
infect
illustr
import
optim
time
specimen
collect
optim
specimen
type
diagnosi
definit
natur
histori
viru
may
indic
possibl
site
respiratori
tract
part
bodi
viru
caus
inflamm
damag
common
respiratori
viral
infect
influenza
viral
load
peak
soon
onset
symptom
sever
featur
sar
distinguish
viral
caus
rti
pathogen
potenti
natur
histori
transmiss
dynam
merscov
requir
definit
optim
sampl
type
ascertain
dipeptidyl
peptidas
identifi
receptor
merscov
receptor
express
primari
human
bronchiolar
lung
tissu
thu
viru
abl
infect
lower
respiratori
tract
tissu
gastrointestin
symptom
also
present
patient
infect
merscov
diagnost
test
respiratori
viral
infect
screen
close
contact
tradit
perform
upper
respiratori
tract
sampl
particularli
nasopharyng
swab
specimen
differ
merscov
detect
merscov
choic
appropri
respiratori
tract
specimen
diagnost
purpos
remain
determin
requir
studi
sever
respiratori
tract
sampl
type
obtain
time
patient
studi
requir
defin
natur
histori
merscov
infect
human
viral
load
kinet
time
variou
respiratori
tract
sampl
determin
merscov
shed
variou
nonrespiratori
clinic
sampl
type
urin
stool
blood
effus
time
infect
recoveri
death
correl
viral
load
intens
care
unit
admiss
death
composit
end
point
data
requir
shed
light
merscov
pathogenesi
ascertain
optim
clinic
sampl
diagnosi
guid
optim
infect
control
measur
viral
load
measur
could
also
serv
biomark
monitor
respons
therapi
diseas
activ
predict
prognosi
